Drugs’ maximal residual limits determination methodology and waiting period’s establishing, in the light of E.U. regulations

Abstract

Communitary concept’s related to the drug residues assumption is essential to Romania’s full integration amongst the countries where alimentary security and human consumer’s security have had become national policy. In this respect a concise enumeration of E.U. basic legislative notions, with the specific terminology and of technicalpremises presentation, it is proposed in the aim of Communitary veterinary medicinal product’s residues evaluation as well the MRL’s determination phases in the light of 2377/90 EU Regulation’s understanding.

Keywords

• veterinary drugs
• residual limits
• wainting period
• EU legislation